Nontransplant surgical treatment for advanced heart failure

Current Opinion in Organ Transplantation

Volumn 12, Issue 5, 2007, Pages 515-521

  Marui, Akira ^a   Komeda, Masashi ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy; Functional mitral regurgitation; Regenerative medicine; Surgical ventricular restoration

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GELATIN;

ANNULOPLASTY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CELL THERAPY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEFIBRILLATION; DEVICE; DRUG DELIVERY SYSTEM; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART PERFORMANCE; HEART SURGERY; HEART VALVE SURGERY; HUMAN; LONG TERM CARE; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REGENERATIVE MEDICINE; REVIEW; SURGICAL TECHNIQUE; SURVIVAL;

EID: 34648852321     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3282efe034     Document Type: Review

References (62)

1. Phillips HR, O'Connor CM, Rogers J. Revascularization for heart failure. Am Heart J 2007; 153:S65-S73. An excellent and comprehensive review of mechanisms of ischemic dilated cardiomyopathy, and medical/surgical strategies of coronary revascularization.
2. De Bonis M, Alfieri O. Surgery insight: surgical methods to reverse left ventricular remodeling. Nat Clin Pract Cardiovasc Med 2006; 3:507-513.
3. Buckberg GD. Ventricular restoration - a surgical approach to reverse ventricular remodeling. Heart Fail Rev 2004; 9:233-239.
4. Herre J. Keys to successful cardiac resynchronization therapy. Am Heart J 2007; 153 (Suppl):18-24.
5. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352:2174-2183.
6. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151-1158.
7. Rizzello V, Poldermans D, Schinkel AF, et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart 2006; 92:239-244.
8. Tarakji KG, Brunken R, McCarthy PM, et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 2006; 113:230-237.
9. Bax JJ, Schinkel AF, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004; 110 (Suppl 1):II18-II22.
10. Cleland JG, Coletta AP, Clark AL. Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet. Eur J Heart Fail 2007; 9:740-745. Latest data from clinical trials including PARR-2 that shows that variability testing did not improve outcome of coronary revascularization.
11. Burkhoff D, Wechsler AS. Surgical ventricular remodeling: a balancing act on systolic and diastolic properties. J Thorac Cardiovasc Surg 2006; 132:459-463. An excellent and concise editorial that emphasizes the limitations of SVR and the importance of balancing the surgery.
12. Athanasuleas CL, Buckberg GD, Stanley AW, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to postinfarction ventricular dilation. J Am Coll Cardiol 2004; 44:1439-1445.
13. Doenst T, Velazquez EJ, Beyersdorf F, et al. To STICH or not to STICH: we know the answer, but do we understand the question? J Thorac Cardiovasc Surg 2005; 129:246-249.
14. Suma H, Horii T, Isomura T, et al. A new concept of ventricular restoration for nonischemic dilated cardiomyopathy. Eur J Cardiothorac Surg 2006; 29(Suppl 1):S207-S212.
15. Tulner SA, Steendijk P, Klautz RJ, et al. Surgical ventricular restoration in patients with ischemic dilated cardiomyopathy: evaluation of systolic and diastolic ventricular function, wall stress, dyssynchrony, and mechanical efficiency by pressure-volume loops. J Thorac Cardiovasc Surg 2006; 132:610-620. This paper clearly evaluated the mechanism of SVR in view of systolic and diastolic ventricular function, wall stress, and dyssynchrony.
16. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115:381-386.
17. Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005; 45:381-387.
18. Spoor MT, Geltz A, Bolling SF. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation 2006; 114(Suppl):I67-I71.
19. Braun J, Bax JJ, Versteegh MI, et al. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg 2005; 27:847-853.
20. Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007; 49:2191-2201. This is the latest report that investigates the efficacy of the concomitant mitral annuloplasty in patients with moderate to severe FMR.
21. Cheng A, Nguyen TC, Malinowski M, et al. Effects of undersized mitral annuloplasty on regional transmural left ventricular wall strains and wall thickening mechanisms. Circulation 2006; 114 (Suppl):I600-I609.
22. Kuwahara E, Otsuji Y, Iguro Y, et al. Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation 2006; 114 (Suppl):I529-I534.
23. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001; 122:674-681.
24. De Bonis M, Lapenna E, La Canna G, et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the 'edge-toedge' technique. Circulation 2005; 112 (Suppl):I402-I408.
25. Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg 2002; 74:600-601.
26. Tibayan FA, Rodriguez F, Zasio MK, et al. Geometric distortions of the mitral valvular-ventricular complex in chronic ischemic mitral regurgitation. Circulation 2003; 108 (Suppl 1):II116-II121.
27. Langer F, Schafers HJ. RING plus STRING: papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007; 133:247-249.
28. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation 2001; 104:1958-1963.
29. Messas E, Pouzet B, Touchot B, et al. Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation. Circulation 2003; 108 (Suppl 1):II111-II115.
30. Messas E, Yosefy C, Chaput M, et al. Chordal cutting does not adversely affect left ventricle contractile function. Circulation 2006; 114 (1 Suppl):I524-I528.
31. Borger MA, Murphy PM, Alam A, et al. Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007; 133:1483-1492.
32. Nielsen SL, Timek TA, Green GR, et al. Influence of anterior mitral leaflet second-order chordae tendineae on left ventricular systolic function. Circulation 2003; 108:486-491.
33. Rodriguez F, Langer F, Harrington KB, et al. Importance of mitral valve second-order chordae for left ventricular geometry, wall thickening mechanics, and global systolic function. Circulation 2004; 110 (Suppl 1):II115-II122.
34. Fukuoka M, Nonaka M, Masuyama S, et al. Chordal 'translocation' for functional mitral regurgitation with severe valve tenting: an effort to preserve left ventricular structure and function. J Thorac Cardiovasc Surg 2007; 133:1004-1011.
35. Tibayan FA, Rodriguez F, Langer F, et al. Does septal-lateral annular cinching work for chronic ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2004; 127:654-663.
36. Nguyen TC, Cheng A, Tibayan FA, et al. Septal-lateral annular cinching perturbs basal left ventricular transmural strains. Eur J Cardiothorac Surg 2007; 31:423-429.
37. Grossi EA, Saunders PC, Woo YJ, et al. Intraoperative effects of the Coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann Thorac Surg 2005; 80:1706-1711.
38. Grossi EA, Woo YJ, Schwartz CF, et al. Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: impact on the left ventricle. J Thorac Cardiovasc Surg 2006; 131:1095-1098.
39. Acker MA, Bolling S, Shemin R, et al., Acorn Trial Principal Investigators and Study Coordinators. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 2006; 132:568-577.
40. Mack MJ. Percutaneous mitral valve repair: a fertile field of innovative treatment strategies. Circulation 2006; 113:2269-2271.
41. Maselli D, Guarracino F, Chiaramonti F, et al. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation 2006; 114:377-380.
42. Dzemali O, Bakhtiary F, Dogan S, et al. Perioperative biventricular pacing leads to improvement of hemodynamics in patients with reduced left-ventricular function - interim results. Pacing Clin Electrophysiol 2006; 29:1341-1345.
43. Di Donato M, Toso A, Dor V, et al. Surgical ventricular restoration improves mechanical intraventricular dyssynchrony in ischemic cardiomyopathy. Circulation 2004; 109:2536-2543.
44. DiDonato M, Sabatier M, Dor V, et al. Ventricular arrhythmias after LV remodelling: surgical ventricular restoration or ICD? Heart Fail Rev 2004; 9:299-306.
45. Stulak JM, Dearani JA, Daly RC, et al. Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status. Ann Thorac Surg 2006; 82:494-500.
46. Damiano RJ Jr, Schuessler RB, Voeller RK. Surgical treatment of atrial fibrillation: a look into the future. Semin Thorac Cardiovasc Surg 2007; 19:39-45. An excellent and comprehensive review of future directions in atrial fibrillation surgery in view of ablation lesion set, technology, atrial electrophysiology and function.
47. Marui A, Nishina T, Tambara K, et al. A novel atrial volume reduction technique to enhance the Cox maze procedure: initial results. J Thorac Cardiovasc Surg 2006; 132:1047-1053.
48. Marui A, Tambara K, Tadamura E, et al. A novel approach to restore atrial function after the maze procedure in patients with an enlarged left atrium. Eur J Cardiothorac Surg 2007; 132:708-712.
49. Simons M, Bonow RO, Chronos NA, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 2000; 102:E73-E86.
50. Jolicoeur EM, Granger CB, Fakunding JL, et al. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am Heart J 2007; 153:732-742. This paper comprehensively reviews the recent advent of cell-based therapy in the cardiovascular area, and its indications, limitations and considerations.
51. Hagege AA, Marolleau JP, Vilquin JT, et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006; 114 (1 Suppl):I108-I113.
52. Dib N, Michler RE, Pagani FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005; 112:1748-1755.
53. + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007; 133:717-725.
54. Hendrikx M, Hensen K, Clijsters C, et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006; 114 (1 Suppl):I101-I107.
55. Schumacher B, Pecher P, Von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardiumby human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998; 97:645-650.
56. Pecher P, Schumacher BA. Angiogenesis in ischemic human myocardium: clinical results after 3 years. Ann Thorac Surg 2000; 69:1414-1419.
57. Laham RJ, Sellke FW, Edelman ER, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999; 100:1865-1871.
58. Ruel M, Laham RJ, Parker JA, et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 2002; 124:28-34.
59. Kanemitsu N, Tambara K, Premaratne GU, et al. Insulin-like growth factor-1 enhances the efficacy of myoblast transplantation with its multiple functions in the chronic myocardial infarction rat model. J Heart Lung Transplant 2006; 25:1253-1262.
60. Takaba K, Jiang C, Nemoto S, et al. A combination of omental flap and growth factor therapy induces arteriogenesis and increases myocardial perfusion in chronic myocardial ischemia: evolving concept of biologic coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006; 132:891-899.
61. Tambara K, Premaratne GU, Sakaguchi G, et al. Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation 2005; 112 (Suppl):I129-I134.
62. Molin D, Post MJ. Therapeutic angiogenesis in the heart: protect and serve. Curr Opin Pharmacol 2007; 7:158-163.